3rd October 2026, Saturday

Latest Posts

HealthTech News

  • A heart valve that grows up with the patient wins FDA approval
    on October 2, 2026 at 11:20 pm

    Children born with certain heart defects may face fewer open-heart surgeries, thanks to a new replacement valve that grows with them.

  • Here’s why experts say now is an ideal time to protect yourself from flu
    on October 2, 2026 at 9:40 pm

    It’s October and time for flu shots. Medical experts urge getting a flu vaccination soon, before influenza starts spreading widely—and to get up to date on protection against other fall respiratory viruses, too. Updated COVID-19 shots are available now, plus shots for people especially vulnerable to another winter risk called RSV.

  • Life expectancy almost back to pre-COVID-19 levels, says WHO
    on October 2, 2026 at 7:40 pm

    Global life expectancy is close to the levels seen before the COVID-19 pandemic, but the outlook for years lived in good health is recovering more slowly, the WHO said Friday.

  • More active teens report fewer sleep problems down the line, new study reveals
    on October 2, 2026 at 7:20 pm

    Pulling an all-nighter before a test or assignment deadline is almost a teenage rite of passage, but scientists are concerned that these exceptions are becoming a regular habit. Insomnia symptoms during adolescence are linked to a range of adverse health and developmental outcomes. Studies have found that physical activity can be a good antidote to sleep issues, but can it help ease adolescent insomnia?

  • Study across 8 European countries demonstrates feasibility of screening children for type 1 diabetes
    on October 2, 2026 at 7:20 pm

    New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct. 2), reports on pilot screening programs for type 1 diabetes in eight countries. The authors—a consortium including Dr. Peter Achenbach and professor Anette-Gabriele Ziegler from the Institute of Diabetes Research, Helmholtz Munich, Munich, Germany—say that screening should be rolled out across Europe, ideally with three testing windows: ages 2–4, 6–8 and 10–15.